• More than 20 years of experience in biopharmaceutical industry as research project leader, manager and laboratory head. • Working collaboratively in integrated project teams with medicinal chemists and in vitro and in vivo biologists to discover new small molecule drug candidates. Activities range from target identification, target validation, development of in vitro and in vivo models for testing compounds, demonstration of efficacy in disease-relevant animal models, working with CRO’s to advance team objectives, pre-clinical ADME studies supporting IND-track nomination, and working within a pre-clinical development team toward IND filings. • Experience with drug discovery projects across several therapeutic areas, including oncology and fibrotic disorders of the kidney, liver and lung. • Experience with multiple target classes, including protein kinases, G-protein-coupled receptors and cytochrome P450 enzymes.• As principal investigator successfully secured funding from the National Institutes of Health for multiple translational research projects, leading to the successful identification of several lead compounds, IND-track candidates, with one drug candidate currently in Phase 2 clinical trials.